Clinical Trial Update: A Study to Evaluate the Safety, Tolerability and Efficacy of a Liproca® Depot Injection in Patients With Prostate Cancer [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating safety, tolerability, and efficacy of Liproca Depot Injection in patients with Prostate Cancer has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Drugs mentioned

• Liproca Depot Injection (Liproca Depot Injection)

Snippet

Sponsor: Lidds AB | Conditions: Prostate Cancer | Phase 2 | Status: COMPLETED